The domestic pure benzene market fluctuated on January 20
Introduction to pure benzene: Yesterday, the domestic market of pure benzene was volatile, and the price of the external market rose in an all-round way. As the price of the external market in the United States continued to rise recently, the arbitrage window from North Asia to the United States was reopened. Near the end of the year, the domestic market was quiet, the trading atmosphere was poor, the downstream derivatives profits hung upside down, and some businesses stopped to exit the market. Aftermarket forecast: due to the impact of logistics parking, the trading volume in the site is relatively small, and it is temporarily expected that the short-term pure benzene market will be sorted within the range.
2026-10-07
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Benzine vs Benzene: Key Differences and Implications
-
What Is Inorganic Benzene? Differences, Similarities, and Structure
-
Global pure benzene and styrene trading biased towards spot
-
What You Need to Know About Benzene in Soda Pop
-
Get to know whether benzene is a hydrocarbon
-
Go Up And Go Up! PET Rose by More Than 80%! With Many Favorable Promotions, Pure Benzene has Broken Through 10,000!
-
South Korea YNCC device incident involving pure benzene upstream and downstream brief
-
Analysis of Import Data of Benzene Anhydride in China
-
The Effect of YNCC Event in Korea on Pure Benzene
-
What Is Kekule Structure of Benzene
Recommend Reading
-
"Zipper-Like" Opening and Closing of Hormuz Coupled with Russian Export Ban Send Energy and Chemical Prices Soaring
-
Canada Launches Re-Evaluation of Herbicide Iodosulfuron-Methyl-Sodium
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
Selling the Family Silver for a New Suit? Why Bohai Chemical’s Transformation Drama Got Canceled After Just Two Acts
-
EU Authorises Propionic Acid and Its Salts as Feed Additives Until 2035
-
Cost Reduction, Weak Demand: December Phthalic Anhydride Prices Fluctuate and Decline
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Insufficient Cost and Demand Support; PTA Prices to Weaken
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods